J.L. Pujol

Motion of the cerebellar tonsils in Chiari type I malformation studied by cine phase-contrast MRI

J.L. Pujol, C Roig, Antoni Capdevila et al. · Neurology · 1995 · 127 citations

Neurotology, Brain Lesion, Csf Dynamics +18

LBA84 Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial

Solange Peters, J.L. Pujol, Urania Dafni et al. · Annals of Oncology · 2020 · 21 citations · Full text

Radiation Medicine, Lba84 Consolidation Ipilimumab, Radiation Therapy +8

Immune Response Induced in Small-Cell Lung Cancer by Maintenance Therapy With Interferon  

J.L. Pujol, D. J. Gibney, Jingwei Su et al. · JNCI Journal of the National Cancer Institute · 1993 · 16 citations

LBA4 CANOPY-N: A phase II study of canakinumab (CAN) or pembrolizumab (PEM), alone or in combination, as neoadjuvant therapy in patients (pts) with resectable stage Ib–IIIa non-small cell lung cancer (NSCLC)

Tony Mok, J.L. Pujol, M. Tsuboi et al. · Annals of Oncology · 2022 · 15 citations

Neoadjuvant Therapy, Lba4 Canopy-n, Medicine +8

Post study docetaxel in non-small cell lung cancer (NSCLC) patients after discontinuation from a randomized phase III trial of pemetrexed versus docetaxel: An exploratory analysis

J.L. Pujol, Saeeda Shaharyar, C. Kortsik et al. · Journal of Clinical Oncology · 2004 · 12 citations

Advanced Lung Disease, Cancer Management, Clinical Endpoint +16